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Abbreviations 
Aβ, amyloid-beta peptide; AD, Alzheimer’s disease; ADDLs, amyloid-derived diffusible 
ligands; APP, amyloid precursor protein; BSA, bovine serum albumine; CICR, Ca2+-induced 
calcium release; DEVD-pNA, N-acetyl-Asp-Glu-Val-Asp-p-nitroanilide; DMSO, dimethyl 
sulfoxide; DT, dantrolene; DTT, 1,4-dithiotreitol; ECF, enhanced chemifluorescence; ER, 
endoplasmic reticulum; Fura-2/AM, Fura-2 acetoxymethyl ester; HFIP, 1,1,1,3,3,3-
hexafluoro-2-propanol; Indo-1/AM, indo-1 acetoxymethyl ester; IP3R, inositol 1,4,5-
triphosphate receptor; LTP, long-term potentiation; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide; MAP-2, microtubule-associated protein 2; NMDA, N-methyl-
D-aspartate; PBS, phosphate-buffered saline; PLC, phospholipase C; PMSF, 
phenylmethylsulfonyl fluoride; PVDF, polyvinylidene difluoride; RyR, ryanodine receptors; 
RT, room temperature; TBS, tris-buffered saline, ThS, thioflavin S; ThT, thioflavin T. 
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ABSTRACT 
The nature of the toxic form of amyloid-β peptide (Aβ) early involved in Alzheimer’s disease 
(AD) pathology and whether it is the fibrillar or the oligomeric peptide the most deleterious to 
neurons still remain controversial issues. This work was aimed to compare the neurotoxicity 
of different Aβ1-42 assemblies, using “fresh” and “aged” samples enriched in oligomeric and 
fibrillar species, respectively, and also isolated oligomers and fibrils. The results obtained 
with “fresh” and “aged” Aβ1-42 preparations suggested that oligomeric species are more 
toxic to cortical neurons in culture than fibrillar forms, which was confirmed by using isolated 
oligomers and fibrils. In order to further elucidate the mechanisms involved in soluble Aβ 
toxicity, the involvement of endoplasmic reticulum (ER) calcium release in oligomers-
induced apoptosis was evaluated. We observed that oligomeric Aβ1-42 depletes ER Ca2+ 
levels leading to intracellular Ca2+ dyshomeostasis involving phospholipase C activation. 
Moreover, in the presence of dantrolene, an inhibitor of ER Ca2+ release through ryanodine 
receptors, the oligomers-induced apoptosis was prevented demonstrating the involvement of 
ER Ca2+ release.  
 
KEYWORDS 
Alzheimer’s disease, amyloid-beta peptide, oligomers, fibrils, endoplasmic reticulum, calcium 
homeostasis. 
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The in vitro and in vivo neurotoxicity induced by fibrillar amyloid-beta peptide (Aβ) ( Pike et 
al., 1993; Lorenzo and Yankner, 1994) has supported the amyloid cascade hypothesis in 
which seeding of insoluble Aβ1-42 is a causative factor in the pathogenesis of Alzheimer’s 
disease (AD) (Hardy and Selkoe, 2002). However, amyloid plaques do not always correlate 
with neurodegeneration and cognitive decline (Masliah et al., 1994; Mucke et al., 2000; Klein 
et al., 2001). In vivo, small stable oligomers of Aβ1-42 have been isolated from the brain of 
AD patients (Gong et al., 2003) and the levels of soluble Aβ  are well correlated with 
cognitive deficits (McLean et al., 1999; Naslund et al., 2000). Recent studies in animals have 
established a link between natural, as well as synthetic, soluble Aβ oligomers and cognitive 
impairment (Richardson et al., 2003; Cleary et al., 2005; Lesné et al., 2006). In vitro, 
oligomeric and protofibrillar forms of Aβ have been shown to be directly neurotoxic (Lambert 
et al., 1998; Hartley et al., 1999; Deshpande et al., 2006). Despite the significant advances in 
AD research made in the last decade, the nature of the toxic form of Aβ early involved in AD 
pathology and also whether it is the fibrillar or the non-fibrillar peptides that are the most 
deleterious to neurons still remain controversial issues. The above mentioned studies 
emphasize the necessity to clarify the initial response of neurons to the non-fibrillar and 
fibrillar Aβ, in particular to the Aβ1-42 peptide.  
The endoplasmic reticulum (ER) has several important functions including the regulation of 
intracellular Ca2+ homeostasis. Under various conditions, ER function is disturbed leading to 
the accumulation of unfolded proteins and activation of a sporadic ER stress response, also 
known as the unfolded protein response (UPR). When cells are subjected to severe or 
prolonged ER stress, the transcriptional factor CHOP/Gadd153 is induced and apoptotic cell 
death occurs (Kaufman, 1999; Paschen, 2001). ER stress has been implicated in many 
important diseases, including AD (Lindholm et al., 2006). Ferreiro and colleagues (2006) 
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have recently demonstrated that ER Ca2+ release through ryanodine receptors (RyR) and 
inositol 1,4,5-triphosphate receptor (IP3R) contributes to the early increase in intracellular 
Ca2+ levels and to the activation of apoptosis induced by fibrillar Aβ peptide. The present 
paper was aimed to compare the neurotoxic effects of different Aβ1-42 assemblies, namely 
oligomers and fibrils, using “fresh” and “aged” preparations of synthetic Aβ1-42 which are 
enriched in oligomeric or fibrillar species, respectively, and also isolated oligomers and 
fibrils. Furthermore, in this study we investigated the role of ER dysfunction in apoptosis 
induced by oligomeric Aβ1-42 in order to further elucidate the molecular mechanisms 
involved in Aβ oligomers-induced neurodegeneration. We have shown that oligomers are 
more toxic to cortical neurons than fibrils and induce apoptotic cell death through a 
phospholipase C- (PLC) mediated mechanism that involves ER Ca2+ release through channels 
associated with the RyR. Taken together, our findings support the hypothesis that oligomeric 
Aβ plays an important role in AD pathogenesis, being responsible for the early changes that 
lead to neuronal death.  
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EXPERIMENTAL PROCEDURES 
Materials 
Neurobasal medium and B27 supplement were purchased from GIBCO BRL, Life 
Technologies (Paisley, UK). Trypsin, trypsin inhibitor type-II-soybean, deoxyribonuclease I 
(DNase I), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT), protease 
inhibitors, phenylmethylsulfonyl fluoride (PMSF), bovine serum albumine (BSA), 
1,1,1,3,3,3-hexafluoro-2-propanol (HFIP), U-73122 and Thioflavin T (ThT) were obtained 
from Sigma Chemical Co. (St. Louis, MO, USA). Acetoxymethyl ester of Fura-2 (Fura-
2/AM) and Indo-1 (Indo-1/AM), Hoechst 33342 and Alexa Fluor 594 goat anti-mouse IgG 
conjugate were purchased from Molecular Probes (Leiden, Netherlands). The synthetic Aβ1-
42 peptide was from Bachem (Bubendorf, Switzerland). Phenol red-free Ham’s F-12 medium 
was purchased from Cambrex Bio Science (Walkersville, USA). In Situ Cell Death Detection 
Kit, Fluorescein was obtained from Roche Applied Science (Mannheim, Germany). The 
caspase-3 colorimetric substrate N-acetyl-Asp-Glu-Val-Asp-p-nitroanilide (DEVD-pNA), 
ZVAD-fmk and MK801 were obtained from Calbiochem (Darmstadt, Germany). Mouse 
monoclonal antibody 6E10, reactive against residues 1-17 of Aβ was obtained from Signet 
(Deshman, MA, USA). Reagents and apparatus used in immunoblotting assays were obtained 
from Bio-Rad (Hercules, CA, USA), whereas polyvinylidene difluoride (PVDF) membrane, 
goat alkaline phosphatase-linked anti-mouse secondary antibody and the enhanced 
chemifluorescence (ECF) reagent were from Amersham Pharmacia Biotech 
(Buckinghamshire, UK). Low-Range Rainbow prestained protein standard was from 
Amersham Biosciences (USA). The Dako fluorescent mounting medium was purchased from 
DakoCytomation Inc. (Carpinteria, CA, USA). All the others chemicals were obtained from 
Sigma Chemical Co. (St. Louis, MO, USA) or from Merck kgaA (Damstadt, Germany). 
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Primary rat embryo cortical neuronal cultures  
Cortical neurons were isolated from E15-E16 Wistar rat embryos according to the 
method described by Hertz and collaborators (1989) slightly modified (Resende et al., 2007). 
Briefly, removed cortices were aseptically dissected and washed in Ca2+- and Mg2+-free Krebs 
buffer (in mmol/L): NaCl 120, KCl 4.8, KH2PO4 1.2, glucose 13, Hepes 10 (pH 7.4) and then 
incubated in Krebs solution supplemented with BSA (0.3 g/L), containing trypsin (0.5 g/L) 
and DNase I (0.04 g/L), for 10 min at 37 ºC. The tissue digestion was stopped by the addition 
of trypsin inhibitor (type II-S) (0.75 g/L) in Krebs buffer containing DNase I (0.04 g/L), 
followed by a centrifugation at 140 x g for 5 min. After washing the pellet once with Krebs 
buffer, the cells were dissociated mechanically and ressuspended in fresh Neurobasal medium 
with 2 mmol/L L-glutamine, 2% (v/v) B27 supplement, penincillin (100,000 U/L), and 
streptomycin (100 mg/L). 
The cells were seeded on poly-L-lysine (0.1 g/L)-coated dishes at a density of 0.25 x 
106 cells/cm2 for measurement of caspase-3-like activity, 0.125 x 106 cells/cm2 for the MTT 
assay or 0.33 x 106 cells/cm2 for western blotting. For fluorescence studies, neurons were 
mounted on poly-L-lysine-coated glass coverslips at a density of 0.1 x 106 cells/ cm2 or on 
poly-L-lysine-coated dishes at 0.4 x 106 cells/cm2. The cultures were maintained in serum-
free Neurobasal medium supplemented with B27, at 37 °C in a humidified atmosphere of 5% 
CO2/95% air for 5-7 days before treatments in order to allow neuronal differentiation. Under 
these conditions, glial growth is less than 10% (Ferreiro et al., 2006). 
 
Preparation of amyloid-β (Aβ) peptide solutions and treatment protocols 
“Fresh and aged” peptide 
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The synthetic peptide Aβ1-42, corresponding to the neurotoxic amino acid residues of 
the human amyloid-beta protein (Aβ), was dissolved in sterile water, or in a diluted ammonia 
solution to facilitate peptide solubilization, at a concentration of 1 g/L (221.5 µmol/L). Aβ1-
42 aliquots were then stored at -20 ºC until being used (“fresh” Aβ1-42 solution), or were 
incubated for 7 days at 37 ºC (“aged” Aβ1-42 solution).  
The fibril content of both preparations (“fresh” and “aged” Aβ1-42) was analyzed by 
different criteria including the thioflavin T (ThT) fluorimetric assay and immunoblotting with 
the 6E10 antibody. To study the effect of the aggregation state of Aβ1-42 peptide on cell 
viability and apoptosis, different concentrations (0.5-5 µmol/L) of “fresh” or “aged” Aβ1-42 
were added to the culture medium of cortical neuronal cells for 6-24 hr. 
 
Aβ oligomers and fibrils 
Synthetic Aβ1-42 peptide was dissolved in 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) to 1 
mmol/L. The HFIP was then removed in a Speed Vac (Ílshin Lab. Co., Ltd, Ede, The 
Netherlands) and the dried HFIP film was stored at -20 ºC. The peptide film was resuspended 
to make a 5 mmol/L solution in anhydrous dimethyl sulfoxide (DMSO) (Dahlgren et al., 
2002). Aβ1-42 oligomers were prepared by diluting the solution in phenol red-free Ham’s F-
12 medium without glutamine to a 100 µmol/L final concentration and incubated overnight at 
4 ºC (Lambert et al., 1998). The preparation was centrifuged at 15,000 x g for 10 min at 4 ºC 
to remove insoluble aggregates, and the supernatant containing soluble oligomers was 
transferred to clean tubes and stored at 4 ºC. The fibrils were prepared by diluting 5 mmol/L 
Aβ1-42 in DMSO to 200 µmol/L in 100 mmol/L Hepes buffer (pH 7.5) and aged at 37 ºC for 
7 days. The preparation was then centrifuged during 10 min at 15,000 x g at RT, and the 
supernatant containing soluble oligomers was discarded. The pellet containing Aβ fibrils (and 
possibly proto-fibrils) was ressuspended in 100 mmol/L Hepes buffer (pH 7.5). Protein 
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concentrations of Aβ oligomers and fibrils were determined using the Bio-Rad protein dye 
assay reagent. 
 
Aggregation state of Aβ peptide 
The fibril content in Aβ1-42 stock solutions was evaluated by a ThT fluorimetric 
assay as previously described (Hashioka et al., 2005) with some modifications. “Fresh” or 
“aged” Aβ1-42 peptide (221.5 µmol/L) was added to 3 µmol/L ThT in 50 mmol/L glycine-
NaOH buffer (pH 8.5). Fluorescence was monitored at 450 nm excitation and 482 nm 
emission using a Perkin-Elmer LS50B spectrofluorometer. A time scan was performed and 
fluorescence values were measured after the decay reached a plateau and the background 
fluorescence of 3 µmol/L ThT was subtracted. The data from three identical samples in 
separate experiments were then averaged to obtain the final values. 
The presence of different assembly forms (monomers, oligomers and fibrils) of Aβ1-
42 in “fresh” and “aged” preparations and the purity of isolated oligomers and fibrils was 
evaluated by gel electrophoresis and western blot. Aβ samples containing 10 µg of protein, 
were diluted (1:2) with sample buffer [40% (w/v) glycerol, 2% (w/v) SDS, 0.2 mol/L Tris-
HCl, pH 6.8 and 0.005% (w/v) Comassie G-250] and were separated by electrophoresis on a 
4-16% Tris-Tricine SDS gel (Klafki et al., 1996). Samples were not boiled to minimize 
disaggregation prior to electrophoresis. To facilitate the identification of proteins a Low-
Range Rainbow prestained protein standard was used. Proteins were then transferred to PVDF 
membranes, which were further blocked for 1 hr at RT with 5% (w/v) fat-free milk in Tris-
buffered saline (150 nmol/L NaCl, 50 nmol/L Tris, pH 7.6) with 0.1% (w/v) Tween 20 (TBS-
T). The membranes were next incubated overnight at 4 ºC with 6E10 mouse monoclonal 
primary antibody against Aβ diluted in TBS-T with 0.5% (w/v) fat-free milk (1:1000). After 
washing in TBS-T with 0.5% (w/v) fat-free milk, membranes were further incubated for 1 hr 
ACCEPTED  MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 10
at RT with an alkaline phosphatase-conjugated anti-mouse secondary antibody (1:20,000). Aβ 
bands were visualized after membrane incubation with ECF reagent for 5 min, on a Versadoc 
Imaging System.  
 
Cell viability assay 
After treatment of cortical neurons with different concentrations of the Aβ peptides, 
cell viability was evaluated by the MTT assay (Mosmann, 1983), which measures the ability 
of metabolic active cells to form formazan through cleavage of the tetrazolium ring of MTT. 
Neurons were washed in sodium medium (in mmol/L: NaCl 132, KCl 4, NaH2PO4 1.2, MgCl2 
1.4, glucose 6, Hepes 10, and CaCl2 1, pH 7.4) and incubated with MTT (0.5 g/L) for 2 hr at 
37 ºC. The blue formazan crystals formed were dissolved in an equal volume of HCl 0.04 
mol/L in isopropanol and quantified spectrophotometrically by measuring the absorbance at 
570 nm using a microplate reader (Spectra max Plus 384, Molecular Devices). 
 
MAP2 immunocytochemistry 
Cortical neurons grown in glass coverslips, in the presence or absence of Aβ1-42, 
were washed with PBS buffer (pH 7.4), and were fixed with 4% paraformaldehyde (w/v) for 
15 min at RT. Then, the cells were permeabilized for 2 min at with 0.2% (v/v) Triton X-100 
in PBS buffer (pH 7.4) and blocked for 1 hr and 30 min in PBS containing 3% (w/v) BSA. 
The cells were incubated for 1 hr with a mouse anti-microtubule-associated protein-2 (MAP-
2) monoclonal antibody (1:500 dilution in 3% BSA/PBS) and then washed and incubated with 
Alexa Fluor 594 goat anti-mouse IgG antibody conjugate (1:200 dilution in 3% BSA/PBS) for 
1 hr. Finally, coverslips were mounted in Dako fluorescent mounting medium on a 
microscope slide and neurons were visualized in an inverted fluorescence microscope 
Axiovert 200 (Zeiss, Germany).  
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Caspase-3 activity 
Cultured cortical neurons, which were either treated or untreated with the Aβ peptide, 
were scrapped in cold (4 ºC) lysis buffer (in mmol/L): HEPES-Na 25, MgCl2 2, EDTA 1, 
EGTA 1, PMSF 0.1, DTT 2, supplemented with a protease inhibitor cocktail containing 
leupeptin, pepstatin A, chymostatin and antipain (1 g/L each). The cellular extract was rapidly 
frozen and thawed three times, and then centrifuged for 10 min at 20,200 x g at 4 ºC. The 
supernatant was collected and assayed for protein content using the Bio-Rad protein dye assay 
reagent. Aliquots of cellular extracts containing 30 µg of protein were reacted with 100 
µmol/L Ac-DEVD-pNA, a chromogenic substrate for caspase-3, in a reaction buffer 
containing 25 mmol/L Hepes-Na, 10 mmol/L DTT, 10% (wt/vol) sucrose, and 0.1% (wt/vol) 
CHAPS (pH 7.4), for 2 hr at 37 ºC (Cregan et al., 1999). Caspase-3-like activity was 
determined by measuring substrate cleavage at 405 nm in a microplate reader. 
 
Neuronal apoptosis 
Apoptotic cells were identified and quantified based on nuclear DNA morphology by 
staining neurons with the cell-permeable DNA dye Hoechst 33342, as described previously 
by Kruman et al. (1997). Cortical neurons, incubated in the absence or in the presence of 
“fresh” Aβ,  “aged” Aβ, oligomers or fibrils isolated from synthetic Aβ1−42, were washed 
with PBS buffer (pH 7.4) and fixed with 4% (wt/vol) paraformaldehyde for 15 min at RT. The 
cells were then incubated for 5 min with Hoechst 33342 (15 mg/L in PBS, pH 7.4), in the 
dark. Cells with homogeneously stained nuclei were considered to be viable, whereas the 
presence of condensed and fragmented nuclei was indicative of apoptotic cells. Cell death was 
also evaluated by TUNEL staining performed using an In Situ Cell Death Detection Kit, 
Fluorescein according to the manufacturer's directions. Fixed cells were permeabilized in 
ACCEPTED  MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 12
0.1% Triton X-100, supplemented with 0.1% sodium citrate in PBS, for 2 min, on ice. After 
washing, cells were incubated in a mixture of the enzymatic solution with the label solution, 
for 1 hr at 37 °C, in the dark. Finally, cells were washed with PBS and coverslips mounted in 
Dako fluorescent mounting medium on a microscope slide. DNAse pretreated cells were used 
as a positive control. The number of apoptotic cells was counted by using an inverted 
AxiovertMicroscope 200 (Zeiss, Germany). 
 
Ca2+ homeostasis  
The free intracellular cytosolic Ca2+ concentration ([Ca2+]i) was measured using Indo-
1/AM. Untreated or treated cultured cortical neurons were incubated with 3 µmol/L Indo-
1/AM in sodium medium (in mmol/L: NaCl 132, KCl 4, CaCl2 1, MgCl2 1.4, glucose 6, 
HEPES-Na 10, pH 7.4) for 45 min at 37 ºC, in the dark. The cells were then incubated in 
Indo-1/AM-free sodium medium for 15 min to ensure the complete hydrolysis of the dye. The 
Indo-1 fluorescence was measured spectrofluorimetrically using a microplater reader 
(SpectraMax Gemini EM, Molecular Devices) with 350 nm excitation and 410 nm emission. 
Calibration of cytosolic Ca2+ levels was performed using the Ca2+ ionophore ionomycin (3 
µmol/L) and MnCl2 (3 mmol/L). The free [Ca2+]i was calculated as previously described by 
Bandeira-Duarte et al. (1990). 
Changes in cytosolic Ca2+ concentration in individual control or treated cells were 
analysed by calcium imaging using the fluorescent probe Fura-2/AM. Cells plated in 
coverslips were washed 2 times in Krebs buffer (pH 7.4) (in mmol/L: NaCl 132, KCl 4, 
MgCl2 1.4, Glucose 6, HEPES 10, NaHCO3 10, CaCl2 1) and loaded with 5 µmol/L Fura-
2/AM supplemented with 0.2% (w/v) pluronic acid, in Krebs buffer for 40 min at 37 °C, in 
the dark. Afterwards, cells were washed 3 times and the coverslip was assembled to the 
perfusion chamber filled with 500 µL of Krebs buffer, in an inverted fluorescence microscope 
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axiovert 200 (Zeiss, Germany). Cells were alternately excited at 340 and 380 nm using a 
Lambda DG4 apparatus (Sutter Instruments company, Nocato, Ca, USA), and emitted 
fluorescence was collected with a 40x objective and was driven to a coll SNAP digital camera 
(Roper Scientific, Trenton, NJ, USA). After a baseline was established, cells were stimulated 
with Aβ oligomers (0.5 µmol/L). To assess extracellular Ca2+ contribution, recording of 
Fura2-AM fluorescence was also performed in Ca2+- free Krebs buffer, supplemented with 50 
µmol/L EGTA. To evaluate the involvement of PLC, cells were pre-incubated with PLC 
inhibitor U-73122 (5 µmol/L) for 10 min, before Fura2-AM fluorescence recording.  
ER Ca2+ content was assessed by single cell Ca2+ imaging, according to the method 
described by Ferreiro and colleagues (2008). After a baseline was established in free Ca2+ - 
free Krebs buffer, cells were stimulated with thapsigargin (2.5 µmol/L final concentration), to 
empty [Ca2+]ER stores. Acquired values were processed using the MetaFluor software 
(Universal Imaging Corporation, Buckinghamshire, UK). The peak amplitude of Fura-2 
fluorescence (ratio at 340/380 nm) was used to evaluate cytosolic Ca2+ content. 
 
Statistical analysis 
Data were expressed as the means ± SEM of the indicated number of experiments. 
Statistical significance was determined by using one-way ANOVA followed by Tukey post-
hoc tests. The differences were considered significant for p values < 0.05. 
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RESULTS 
“Fresh” and “aged” Aβ1-42 peptide solutions have different fibril content 
In this paper, we analyzed the effect of different Aβ1-42 assemblies on neuronal cell 
viability and apoptotic death. For that purpose, we prepared “fresh” and “aged” Aβ1-42 
peptide solutions, which were characterized by ThT fluorescence and western blotting. The β-
sheet content and, therefore, of fibrils of “aged” Aβ1-42, prepared after incubation of the 
peptide solution for 7 days at 37ºC, were significantly higher in comparison with that 
determined in “fresh” Aβ1-42, used immediately after peptide solubilization (Fig. 1A). Low-
molecular weight oligomers of Aβ1-42 (~14 kDa) were preferentially detected in “fresh” 
samples while fibrillar Aβ1-42 (high molecular weight bands) was the predominant species 
detected in “aged” samples (Fig. 1B). Taken together, our results clearly show that “fresh” 
and “aged” Aβ1-42 preparations have a significantly different fibril content, the former being 
enriched in oligomeric forms and the later in fibrillar Aβ.  Furthermore, the preformed fibrils 
of the “aged” peptide are not dissociated when the peptide is diluted into the culture medium 
as evaluated by fluorescence microscopy using thioflavin S (ThS) (data not shown). Thus, 
“fresh” and “aged” Aβ1-42 preparations are suitable to evaluate the differential effect of 
Aβ assemblies. 
 
“Fresh” Aβ1-42 peptide is more toxic in comparison with the “aged” peptide  
After 6 hr incubation of primary cortical neuronal cultures, in the absence or in the 
presence of increasing concentrations (0.5-5 µmol/L) of “fresh” or “aged” Aβ1-42 peptide, 
cell viability was analyzed by the MTT reduction assay. It was observed that at all tested 
concentrations, both “fresh” and “aged” Aβ1-42 are toxic to cortical neurons, significantly 
decreasing (p<0.001) the reduction of the tetrazolium salt (Fig. 2A). However, for the same 
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concentration (1 and 5 µmol/L), the “fresh” peptide was shown to be more toxic as compared 
to the “aged” peptide (p<0.05 and p<0.001).  
Similar results were obtained when the number of apoptotic cells was determined in 
“fresh” or “aged” Aβ1-42-treated neurons (Fig. 2B). After 24 hr incubation, “fresh” Aβ1-42 
was shown to be more effective than the “aged” peptide, significantly increasing the number 
of cells exhibiting apoptotic morphology as evaluated by using Hoechst 33342. These results 
were further confirmed using Tunel staining (Fig.4). Taken together, the results obtained 
demonstrate that Aβ1-42-induced toxicity and cell death correlate with the aggregation state 
of the peptide and suggest that the soluble oligomeric forms are the main toxins against 
cortical neurons. 
 
“Fresh” Aβ1-42 peptide impairs Ca2+ homeostasis and leads to dendritic dystrophy and 
caspase-3 activation 
As the “fresh” Aβ1-42 is more toxic than the “aged” peptide, we decided to perform 
some experiments using this peptide preparation enriched in oligomers in order to understand 
the mechanisms that underly the toxicity of soluble Aβ species.  To investigate the effect of 
soluble Aβ on the intracellular Ca2+ homeostasis, the basal [Ca2+]i concentration was 
measured in control and in cortical neurons treated with “fresh” Aβ1-42 during 6 or 24 hr. 
Cytosolic Ca2+ levels were significantly higher (p<0.05) in cortical neurons treated with Aβ1-
42 for 6 hr comparing with the control and this Ca2+ rise persisted 24 hr after addition of 
“fresh” Aβ1-42 (Fig. 3).  
The analysis of dendritic morphology gives important information about neuronal 
health and synaptic integrity. We evaluated dendritic integrity in Aβ1-42-treated cortical 
neurons immunostained against MAP2 which was compared with that obtained in neurons 
treated with “aged” Aβ peptide (Fig. 4). Untreated cortical cells (control) showed a complex 
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dendritic network with smooth and long dendritic arborization (Fig. 4a). On the other hand, 
cultured neurons exposed to 5 µmol/L Aβ1-42 for 24 hr showed loss and retraction of the 
dendritic arborization (Fig. 4b, c). This effect is more pronounced in “fresh” Aβ-treated 
neurons (Fig. 4b). 
The activity of caspase-3, an effector caspase in the apoptotic cell death pathway was 
measured in cortical neurons treated with 5 µmol/L “fresh” Aβ1-42 during 12 or 24 hr (Fig. 
5A). Results obtained have demonstrated that “fresh” Aβ induces caspase-3 activation upon 
12 hr treatment (p<0.05) which persists after 24 hr treatment. In order to evaluate the 
functional involvement of caspases in Aβ1-42-induced toxicity, ZVAD-fmk, a broad range 
caspase inhibitor was used. In the presence of 25 µmol/L ZVAD-fmk the increase in [Ca2+]i 
was prevented (Fig. 5B) suggesting the involvement of caspases in Aβ-induced Ca2+ 
dyshomeostasis. Furthermore, in the presence of ZVAD-fmk the increase in the number of 
apoptotic cells triggered by “fresh” Aβ1-42, determined by fluorescence microscopy using 
Hoechst 33342, was shown to be abolished (Fig. 5C). 
 
Aβ1-42 oligomers are more toxic than fibrils  
Our results obtained using “fresh” and “aged” Aβ1-42, enriched in oligomers and 
fibrils respectively suggest that soluble oligomeric forms of the Aβ peptide are more potent 
neurotoxins than fibrils. In order to validate these results, we isolated oligomers and fibrils 
accordingly to procedures previously published (Dahlgren et al., 2002; Lambert et al., 1998) 
which were characterized by immunoblotting with the 6E10 antibody. As shown in Fig. 6, 
oligomeric preparation (Aβ1-42O) is composed only of low-n oligomers (~14 kDa) and the 
fibrillar preparation (Aβ1-42f) is mainly composed of fibrils although smaller amounts of 
oligomers are also detected. 
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 In cortical neurons, a significant decrease in cell viability was observed after 6 or 24 
hr treatment with Aβ oligomers (p<0.01), as demonstrated by the MTT assay (Fig. 7A). At 0.5 
and 1 µmol/L, Aβ1-42 oligomers were shown to be more toxic than fibrils (Fig 7B). At the 
same concentration, Aβ1-42 fibrils significantly decreased cell viability only after 24 hr 
treatment (p<0.05). Moreover, oligomers decreased cell survival more effectively than fibrils 
at all time points tested (p<0.05; p<0.001). The same results were obtained when the 
apoptotic cell number was determined after 24 hr treatment with oligomeric or fibrillar Aβ1-
42 species (Fig. 7C). The increase in the number of apoptotic cells observed in oligomers-
treated neurons was more pronounced (p<0.05) than that measured in cells incubated with 
fibrils. These data are in agreement with the results obtained with “fresh” and “aged” Aβ1-42 
preparations.  
 
Aβ  oligomers-induced apoptosis is mediated through endoplasmic reticulum Ca2+ release 
In cortical neurons treated with oligomeric Aβ1-42 (0.5 µmol/L) during 6 or 24 hr, the 
intracellular Ca2+ concentration was measured spectrofluorimetrically using Indo-1/AM. A 
significant increase in cytosolic Ca2+ levels was observed after 6 hr treatment with oligomeric 
Aβ compared with controls, which persisted until 24 hr incubation (Fig. 8). Dantrolene (DT), 
an inhibitor of ER Ca2+ release through channels associated to RyR, was shown to prevent the 
Aβ1-42 oligomers-induced rise of [Ca2+]i, suggesting the involvement of Ca2+ release by ER. 
To further investigate the involvement of ER on the impairment of Ca2+ homeostasis 
triggered by Aβ oligomers, ER Ca2+ content was analyzed indirectly using thapsigargin, an 
inhibitor of the ER Ca2+ ATPase that releases Ca2+ from ER stores, in the absence of 
extracellular Ca2+. A representative trace of Fura-2 fluorescence ratio at 340 nm and 380 nm 
is presented in Fig. 9A. After a baseline was established, cells were stimulated with 
thapsigargin, to empty [Ca2+]ER stores. In control neurons, there was an increase in free 
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[Ca2+]i after the addition of thapsigargin. In treated neurons, this increase was not observed 
since Aβ oligomers have already induced the leak of Ca2+ from this intracellular organelle. 
The content of ER Ca2+ was evaluated by the calculation of the peak over baseline, obtained 
after thapsigargin addition and the results normalized to values determined in untreated 
cortical neurons. Figure 9B show that treatment with Aβ-42 oligomers for 1 hr induce a 
significant decrease in the ER Ca2+ content (p<0.001), which was more pronounced 24 hr 
after the addition of oligomers. 
The inhibition of Ca2+ release from ER with DT (10 µmol/L) also prevented the 
apoptotic cell death that was observed in cortical neurons after exposure to Aβ1-42 oligomers 
(0.5 µmol/L) for 24 hr (Fig. 10). Together, these results demonstrate that the early release of 
Ca2+ from ER in cortical neurons exposed to oligomeric Aβ1-42 species leads to the 
perturbation of Ca2+ homeostasis and subsequently to apoptotic cell death.  
 
IP3-PLC pathway is involved in the perturbation of ER Ca2+ homeostasis induced by 
Aβ  oligomers 
To analyze whether the entry of Ca2+ through Ca2+ channels present in the plasma 
membrane also contributes to the increase of cytosolic Ca2+ concentration upon treatment 
with Aβ oligomers, cortical neurons were loaded with the Ca2+-sensitive fluorescent dye Fura-
2/AM and the Ca2+ content in the cytosol was analyzed by single cell Ca2+ imaging in the 
presence or in the absence of extracellular Ca2+. After 4 min recording, Aβ oligomers (0.5 
µmol/L) were added to the cells. Few seconds after Aβ addition, Fura-2 fluorescence ratio at 
340 nm and 380 nm (F340/F380) significantly increased in cells treated either in the presence 
or in the absence of Ca2+ in the medium. However, in the absence of Ca2+, this increase was 
smaller than in the presence of Ca2+ (Fig. 11A). The increase in cytosolic Ca2+ content was 
determined by measuring the peak over baseline obtained after Aβ oligomers addition. Figure 
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11B depicts that the increase of cytosolic Ca2+ content is significantly higher in Aβ-treated 
cells in the presence of extracellular Ca2+ than in Ca2+- free medium (p<0.01). These results 
indicate that the entry of Ca2+ through channels at the plasma membrane also contribute to the 
increase of intracellular Ca2+ induced by Aβ oligomers. To further investigate this hypothesis, 
we evaluated the involvement of NMDA receptors by using the MK801 which is an 
antagonist of these receptors. In the presence of 2 µmol/L MK801, the increase in the [Ca2+]i  
was partially prevented (Fig. 12A) but it does not affect the Aβ oligomers-induced apoptotic 
cell death (Fig. 12B) . 
The increase in cytosolic Ca2+ content upon ER Ca2+ depletion induced by Aβ 
oligomers can be related to the  activation of PLC, leading to the formation of diacylglycerol 
(DAG) and inositol 1,4,5-trisphosphate (IP3) that subsequently mediates the release of Ca2+ 
from ER through IP3R and potentiates Ca2+ release by RyR (Ca2+-induced Ca2+ release, 
CICR) (Mikoshiba, 2006). To evaluate whether IP3-PLC pathway is involved in the [Ca2+]i 
increase induced by Aβ oligomers, cortical neurons were pre-incubated with the PLC 
inhibitor U-73122, loaded once again with Fura-2/AM, and stimulated with Aβ oligomers (0.5 
µmol/L). The increase in F340/F380 ratio observed in Aβ oligomers-treated cells was 
prevented by U-73122 in the presence or absence of extracellular Ca2+, suggesting the 
involvement of IP3-PLC signalling in the intracellular Ca2+ mobilization by Aβ oligomers 
(Fig. 11 A and B, p<0.05). 
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DISCUSSION 
Aβ peptide exists in several different conformations, including monomers, oligomers, 
amyloid-derived diffusible ligands (ADDLs), protofibrils and fibrils. A strong correlation 
between soluble Aβ levels, and the extent of synaptic loss and cognitive impairment was 
described (Mclean et al., 1999; Klein et al., 2001; Lacor et al., 2004), suggesting that soluble 
oligomers of Aβ are the toxic assembly of the peptide that causes the synaptic dysfunction 
and dementia associated with the disease. However, the relative contribution of fibrillar and 
soluble oligomeric Aβ to neurodegeneration and dementia in AD has not yet been clearly 
established.  
We here addressed the possibility that soluble oligomers and fibrillar (plaque-forming) 
Aβ1-42 peptide exert a differential effect on neurons. To test this hypothesis, we investigated 
the conformation-dependent effect on neuronal viability and activation of apoptotic cell death 
of different Aβ assemblies in vitro. Cortical neurons were exposed to “fresh” or “aged” Aβ1-
42, which are enriched in low-molecular-weight oligomers (and possibly protofibrils) or have 
a significant high content in amyloid fibrils, respectively, as revealed by ThT staining and 
western blotting. By doing this, we intended to mimic what happens in the brain of AD 
patients in which the concentration of different Aβ1-42 assemblies varies depending on brain 
region, proximity to plaques and the stage of disease. The fact that the Aβ peptide exists in 
vivo as a mixture of peptides with different oligomerization states supports the use of our 
preparations (“fresh” and “aged” Aβ1-42) to directly compare the effects of distinct 
assemblies of Aβ. Our data, obtained using primary embryonic cortical neurons in culture 
treated with “fresh” or “aged” Aβ1-42, demonstrate that both assemblies of Aβ1-42 are toxic 
to neurons. However, in comparison with fibrils-enriched Aβ1-42 preparations, Aβ samples 
enriched in oligomers caused a significantly greater decrease in cell viability and a higher 
increase in the extent of apoptotic death than fibrils. In addition, an early activation of 
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apoptosis was shown to occur upon exposure to “fresh” Aβ1-42. Although the monomeric 
content is higher in “fresh” Aβ which was shown to be more toxic, it does not seem 
reasonable to attribute the toxicity to the presence of monomers. It has been shown that unlike 
the oligomers, the monomeric form of Aβ peptide does not increase intracellular Ca2+ levels 
(Demuro et al., 2005) and does not affect neither LTP (long term potentiation) (Walsh et al., 
2002; Townsend et al., 2006) nor EPSC (excitatory post-synaptic current) activity (Cleary et 
al., 2005). Indeed, monomeric Aβ peptide has been described as antioxidant and 
neuroprotective (Zou et al., 2002). Therefore, the differential results obtained with “fresh” or 
“aged” Aβ1-42 can be attributed solely to the presence of soluble oligomers or fibrils, 
respectively. These results were validated using oligomers (low-n oligomers, probably 
trimers) and fibrils isolated from synthetic Aβ1-42 being the oligomers more toxic than 
fibrils. The fibrils preparation, obtained accordingly to previously published protocols, were 
shown to have not only fibrils but also oligomers. However, this preparation was not as toxic 
as the oligomeric Aβ preparation. We cannot exclude the hypothesis that the toxicity induced 
by the different samples of the Aβ peptide is due to the presence of the oligomers and if so, 
the fibrils can be protective. Indeed, Shimmyo and collegues (2007) recently demonstrated 
that structural changes in Aβ1-42 from a random coil to a beta-sheet-rich structure protect 
cortical neurons from apoptotic cell death and caspase-3 activation. 
The neurotoxic effect of aggregated Aβ has been associated with oxidative stress 
(Behl et al., 1994; Pereira et al., 1999; Ferreiro et al., 2006; Resende et al., 2007), 
mitochondrial damage (Pereira et al., 1998; Cardoso et al., 2001; Casley et al., 2002) and 
intracellular Ca2+ dyshomeostasis (Mattson et al., 2002, Ferreiro et al., 2006). The fibrillar Aβ 
peptide has been shown to induce apoptosis in neurons involving both the mitochondrial-
mediated and the ER stress-mediated apoptotic pathways (Ferreiro et al., 2004, 2006, in 
press) which may contribute to the neuronal degeneration in AD. In addition, neuritic 
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dystrophy and synaptic loss were shown to be induced by fibrillar Aβ (Grace et al., 2002; 
Grace and Busciglio, 2003; Resende et al., 2007). Deposition of fibrillar Aβ was also 
described to be associated with neurite breakage and permanent disruption of neuronal 
connections (Tsai et al., 2004). However, because insoluble protein aggregates are likely 
surrounded by oligomers it is difficult to ascertain whether the large aggregates are 
responsible for local neuronal dysfunction. Several in vitro studies as well as studies using 
animal models of AD show that soluble oligomeric forms (and protofibrils) of Aβ, 
intermediates in the formation of fibrils by synthetic Aβ, are the main neurotoxins for neurons 
which are responsible for the synaptic dysfunction that occurs in the early stages of the 
disease (Lambert et al., 1998; Hartley et al., 1999; Walsh et al., 2002). Naturally secreted low-
n Aβ oligomers (dimers and trimers) induce progressive loss of hippocampal synapses 
(Shankar et al., 2007) and disrupt cognitive function (Cleary et al., 2005). Aβ oligomers 
disrupt Ca2+ homeostasis in primary neuronal cultures (De Felice et al, 2007b; Kelly et al., 
2006). It has also been demonstrated that soluble oligomeric Aβ induces oxidative stress (De 
Felice et al., 2007) and tau phosphorylation (De Felice et al., 2007b; Resende et al., 2008). 
The oligomers that we obtained are low-n oligomers, probably trimers. Shankar and 
colleagues (2007) showed that naturally secreted Aβ dimers and trimers induce progressive 
loss of hippocampal synapses. Demuro and colleagues (2005) demonstrated the involvement 
of these forms in Ca2+ dyshomeostasis and proposed that a rise in intracellular 
Ca2+concentration is mainly due to the oligomer-induced increase of the permeability of the 
plasma membrane. The present study demonstrate that “fresh” Aβ1-42, which is enriched in 
low molecular weight oligomeric forms (~14 kDa) perturbs Ca2+ homeostasis causing neuritic 
dystrophy and apoptotic cell death involving caspase-3 activation.  
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One major finding of this work is the involvement of ER Ca2+ release in oligomers-
induced toxicity in cortical neurons. Here, we demonstrated that Aβ oligomers induce the 
early release of Ca2+ from ER, leading to the depletion of ER Ca2+ content after 1 hr treatment. 
In addition, using dantrolene, an inhibitor of ryanodine (RyR) receptors present in the ER, we 
also demonstrated that ER Ca2+ release is involved in the oligomeric Aβ-induced apoptotic 
cell death observed in cortical neurons. Furthermore, we show that Aβ oligomers also induce 
the increase of cytosolic Ca2+ through a process dependent of phospholipase C (PLC) 
signalling. The intracellular Ca2+ levels and the ER Ca2+ content is guaranteed by two 
different processes: the pumping of Ca2+ into the ER by SERCA ATPases and the release of 
Ca2+ by the opening of inositol 1,4,5-triphosphate receptor (IP3R) or RyR Ca2+ releasing 
channels (Berridge et al., 2000), which participate in the signal transduction pathway of 
apoptosis (Guo et al, 1997; Jayaraman and Marks, 1997; Pan et al, 2000). The activation of 
IP3R is indirectly linked to the activity of PLC. When G-protein coupled receptors are 
activated, phospholipase C causes the hydrolysis of phosphatidylinositol (4,5) biphosphate 
(PIP2) to release IP3 and diacylglycerol (DAG) (Dutta, 2000). IP3 further reports the signal to 
the ER by activating IP3R to release ER Ca2+. Both IP3R and RyR channels can be sensitized 
by cytosolic Ca2+, resulting in a process called Ca2+-induced Ca2+ release (Finch et al., 1991; 
Yao et al., 1992; Friel et al., 1992). CICR through RyR can also be triggered and amplified by 
Ca2+ released through IP3R. It was previously shown that PLC is activated by Aβ25-35, the 
fragment that mimics full length Aβ peptide toxicity, and to be a Ca2+-independent 
stimulation (Singh et al., 1997; Hedin et al., 2000) possibly due to a receptor-mediated event, 
activation of G-protein coupled receptors or direct interaction of Aβ with PLC. These data are 
in accordance with the results presented in this work, since the inhibitor of PLC was shown to 
have the same effect on the cytosolic Ca2+ increase induced by Aβ oligomers in the presence 
or in the absence of extracellular Ca2+. Further studies are needed to elucidate how Aβ 
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oligomers activate PLC to release Ca2+ from the ER. Nevertheless, it appears that the 
production of IP3 induced by Aβ oligomers leads to the release of Ca2+ through IP3R that may 
induce CICR and activation of RyR, culminating in exaggerated intracellular Ca2+ levels.  
The contribution of Ca2+ influx through channels at the plasma membrane to the 
increase in cytosolic Ca2+ content cannot be excluded since the rise in [Ca2+]i induced by Aβ 
is attenuated in Ca2+-free medium. The excitoxicity induced by excessive Ca2+ influx through 
channels associated to glutamate NMDA receptors (NMDARs) can be one of the many 
mechanisms through which the Aβ peptide exerts its toxicity. Indeed, the involvement of 
NMDARs on perturbation of Ca2+ homeostasis triggered by Aβ peptides have been published 
(Domingues et al., 2007; Resende et al., 2007). In this work we also evaluated the 
involvement of NMDARs on Aβ oligomers-induced toxicity and results have shown that 
these Aβ species can induce Ca2+ influx through this subtype of glutamate receptors. 
However, blocking the NMDARs with the competitive antagonist MK801 did not protected 
from apoptotic cell death, suggesting that the extracellular Ca2+ has a relative contribution to 
the Aβ oligomers-induced toxicity.  
The in vitro results presented here, obtained using “fresh” and “aged” Aβ1-42 
preparations enriched in oligomers or fibrils, respectively, as well as isolated oligomeric and 
fibrillar species, are consistent with the view that soluble oligomeric forms of the Aβ peptide 
are the main neurotoxic species in AD that are able to initiate neuronal dysfunction in the 
early stages of the disease. Finally, we were able to demonstrate that the neurotoxicity 
induced by oligomeric forms of the Aβ peptide (Aβ1-42 isoform) involves the release of Ca2+ 
from the ER through channels associated with RyR. Oligomers can also activate IP3-PLC 
pathway leading to the release of Ca2+ through IP3R that may induce CICR and activation of 
RyR, culminating in exaggerated intracellular Ca2+ levels. 
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LEGENDS 
 
FIG. 1. Analysis of Aβ1-42 peptide fibrillogenesis in “fresh” and “aged” samples. (A) 
ThT fluorimetric assay in a cell-free system. Increased ThT fluorescence in “aged” peptide 
revealed greater β-sheet content in comparison with the “fresh” peptide. “Fresh” or “aged” 
(221.5 µmol/L) Aβ1-42 peptide was added to 3 µmol/L ThT in 50 mM glycine-NaOH buffer 
(pH 8.5) and fluorescence was monitored at 450 nm excitation and 482 nm emission. The data 
from three identical samples in separate experiments were then averaged to obtain the final 
values. *** p<0.001, significantly different from ThT fluorescence measured in “fresh” Aβ1-
42 samples. (B) Western blotting. “Fresh” and “aged” Aβ1-42 samples were subjected to 
SDS-PAGE and the different assembly states of the Aβ peptide were detected, based on the 
molecular weight, using the monoclonal antibody (6E10) against Aβ. The analysis of the 
representative gel from three independent experiments shows that “fresh” and “aged” Aβ1-42 
samples are enriched in oligomers or fibrils, respectively.  
 
FIG. 2. “Fresh” Aβ1-42 peptide is more toxic to cortical neurons than “aged” peptide. 
A) Cultured cortical neurons were treated for 6 hr with increasing concentrations (0.5-5 
µmol/L) of synthetic Aβ1-42 in a soluble or fibrillar assembly form (peptide added from 
“fresh” or “aged” solution, respectively). After that, cell viability was evaluated by measuring 
the capacity of the cells to reduce MTT. The results were presented as the percentage of the 
absorbance determined for control conditions and represent the means ± SEM of at least three 
independent experiments performed in duplicate. B) Primary cortical neurons cultured in 
glass coverslips were incubated for 24 hr with 1 or 5 µmol/L of both forms (“fresh” or 
“aged”) of the synthetic Aβ1-42 peptide. Thereafter, apoptotic cells were quantified by nuclei 
morphology using Hoechst 33342. Values are means ± SEM of at least three independent 
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experiments performed in duplicate and correspond to the number of apoptotic cells as a 
percentage of total cells analyzed per sample. ***p<0.001, significantly different from 
control, in the absence of Aβ treatment. #p<0.05, ##p<0.01 significantly different from 
cortical cultures exposed to the same concentration of “aged” Aβ peptide. 
 
FIG. 3. Basal [Ca2+]i is increased upon treatment with “fresh” Aβ1-42. Aβ peptide 
increases basal intracellular Ca2+ levels. Primary cortical neurons treated with 5 µmol/L Aβ1-
42 for 6 or 24 hr and the controls were incubated with Indo-1/AM for 45 min. After a 15 min 
post-loading period, the fluorescence of this Ca2+ indicator was measured and the [Ca2+]i was 
calculated. *P<0.05, significantly different from control, in the absence of Aβ treatment. 
 
FIG. 4. Dendritic network dystrophy induced by Aβ1-42. Control neurons exhibit long and 
smooth dendrites, while in Aβ-treated neurons dendritic loss and retraction and the presence 
of dystrophic dendrites is evident with “fresh” Aβ-treated neurons showing a more 
pronounced effect. Primary neurons cultured in glass coverslips (control or treated with 5 
µmol/L “fresh” or “aged” Aβ1−42  for 24 hr) were fixed and immunostained with a mouse 
anti-MAP2 monoclonal antibody (red). Apoptotic cells are stained with Tunel (green). 
Representative images of control and of Aβ1-42-treated neurons were obtained from three 
independent experiments. 630 X. 
 
FIG. 5. “Fresh” Aβ1-42 peptide induces caspase-3 activation. A) After treatment with 5 
µmol/L Aβ1-42 (“fresh” form) for 12 or 24 hr, cultured cortical neurons were lysed and the 
cytosolic proteins were extracted. Caspase-3-like activity was determined by measuring 
cleavage of the chromogenic substrate Ac-DEVD-pNA at 405 nm and was expressed as 
arbitrary units of absorbance and the results represent the means ± SEM of at least three 
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independent experiments.  B) Basal intracellular Ca2+ levels were measured in primary 
cortical neurons using the fluorescent Ca2+ indicator Indo-1/AM. Controls and neurons treated 
with 5 µmol/L “fresh”Aβ for 6 hr, in the absence or in the presence of 25 µmol/L ZVAD-fmk 
were incubated with Indo-1/AM for 45 min, followed by a 15 min post-loading period. 
Finally, Indo-1 fluorescence was recorded and the cytosolic Ca2+ concentration was calculated 
upon calibration with ionomycin and MnCl2. C) Primary cortical neurons cultured in glass 
coverslips were incubated for 24 hr with 5 µmol/L of “fresh” Aβ1-42 peptide in the presence 
or in the absence of 25 µmol/L ZVAD-fmk. Thereafter, apoptotic cells were quantified by 
nuclei morphology using Hoechst 33342. Values are means ± SEM of at least three 
independent experiments performed in duplicate and correspond to the number of apoptotic 
cells as a percentage of total cells analyzed per sample. *P<0.05; ***p<0.001, significantly 
different from control, in the absence of Aβ treatment. ##p<0.01; ###p<0.001, significantly 
different from cortical cultures exposed to 25 µmol/L ZVAD-fmk.  
 
FIG. 6. Aggregation state analysis of isolated Aβ1-42 oligomers and fibrils. Fibrils and 
oligomers isolated from synthetic Aβ1-42 were subjected to SDS-PAGE. Proteins were 
immunoblotted with an anti-Aβ monoclonal antibody (6E10) and immunopositive bands were 
visualized by chemifluorescence. The gel depicts one of three independent experiments that 
gave similar results.  
 
FIG. 7. Aβ1-42 oligomers are more toxic to cortical neurons than Aβ fibrils. A-B) 
Cultured cortical neurons were treated for 6 or 24 hr with oligomers (AβO) or fibrils (Aβf) 
isolated from synthetic Aβ1-42 (0.5 or 1 µmol/L). After that, cell viability was evaluated by 
measuring the ability of the cells to reduce MTT. The results were presented as the percentage 
of the absorbance determined for control conditions (no treatment with Aβ peptide) and 
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represent the means ± SEM of at least three independent experiments performed in duplicate. 
C) Primary cortical neurons cultured in glass coverslips were incubated for 24 hr with 
oligomeric (AβO) or fibrillar (Aβf) Aβ1-42 (0.5 µmol/L). Thereafter, apoptotic cells were 
quantified by nuclei morphology analysis using Hoechst 33342. Values are means ± SEM of 
at least three independent experiments performed in duplicate and correspond to the number 
of apoptotic cells as a percentage of total cells analyzed per sample. *p<0.05; **p<0.01; 
***p<0.001, significantly different from control, in the absence of Aβ treatment. #p<0.05, 
##p<0.01; ###p<0.001 significantly different from cortical cultures exposed to the same 
concentration of AβO or Aβf. 
 
FIG. 8. Dantrolene prevents the Aβ1-42 oligomers-induced increase on basal [Ca2+]i. 
Basal intracellular Ca2+ levels were measured using the fluorescent Ca2+ indicator Indo-1/AM 
in primary cortical neurons. Controls and neurons treated with 0.5 µmol/L Aβ oligomers 
(AβO) for 6 or 24 hr, in the absence or in the presence of 10 µmol/L dantrolene (DT) were 
incubated with Indo-1/AM for 45 min, followed by a 15 min post-loading period. Finally, 
Indo-1 fluorescence was recorded and [Ca2+]i was calculated upon calibration with ionomycin 
and MnCl2. *P<0.05; **P<0.01, significantly different from control, in the absence of Aβ 
treatment. #p<0.05, significantly different from cortical cultures exposed to 10 µmol/L 
dantrolene. 
 
FIG. 9. Depletion of ER Ca2+ content is induced by Aβ1-42 oligomers. Controls and 
cortical neurons treated with 0.5 µmol/L oligomers (AβO) for 1 or 24 hr were loaded with 5 
µmol/L Fura-2/AM for 40 min at 37 °C, in the absence of extracellular Ca2+, and changes in 
fluorescence ratio (F340/F380) were monitored during 2 min. Thapsigargin (2.5 µmol/L) was 
then added to empty ER Ca2+ stores and fluorescence ratio was monitored for an additional 10 
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min period. A) Representative trace of Fura-2 fluorescence ratio is presented.  B) The peak 
amplitude of Fura-2 fluorescence was used to evaluate ER Ca2+ content. Data from at least 
three independent experiments were expressed as the decrease above control values. Data 
were expressed as the means ± SEM. ***p<0.001, significantly different from control. 
 
FIG. 10. Apoptosis induced by Aβ1-42 oligomeric species is prevented by dantrolene.  
Cultured cortical neurons were treated for 24 hr with 0.5 µmol/L of Aβ1-42 oligomers (AβO) 
in the presence or in the absence of 10 µmol/L dantrolene (DT). The number of apoptotic 
cells was quantified in untreated and treated cortical neurons by fluorescence microscopy 
using Hoechst 33342. The results were presented as the percentage of the total number of 
cells and represent the means ± SEM of at least three independent experiments performed in 
duplicate. ***p<0.001, significantly different from control, in the absence of AβΟ treatment.  
###p<0.001 significantly different from cortical cultures exposed to AβΟ alone. 
 
FIG. 11. Plasma membrane Ca2+ channels and phospholipase C activation contributes to 
Aβ oligomers-induced increase in [Ca2+]i. Cortical neurons were loaded with 5 µmol/L 
Fura-2/AM for 40 min at 37 °C, either in the absence (-Ca2+) or in the presence (+Ca2+) of 
extracellular Ca2+, and changes in fluorescence ratio (F340/F380) were monitored during 4 
min. Aβ oligomers (AβO, 0.5 µmol/L) were added to the cells and fluorescence ratio was 
monitored for an additional 8 min period. A group of cells were also pre-incubated with PLC 
inhibitor U-73122 (5 µmol/L) for 10 min, before Fura2-AM fluorescence recording. A) 
Representative trace of Fura-2 fluorescence ratio is presented. B) The peak amplitude of Fura-
2 fluorescence was used to evaluate cytosolic Ca2+ content. Data from at least three 
independent experiments were expressed as the increase above control values. Data were 
expressed as the means ± SEM. **p<0.01, significantly different from control. # p<0.05 
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significantly different from AβO-treated cells. § p<0.05 significantly different from AβO-
treated cells in the presence of extracellular Ca2+. 
 
FIG. 12. MK801 partially prevents increase on basal [Ca2+]i but does not prevent 
apoptosis induced by Aβ1-42 oligomeric species. Cultured cortical neurons were treated for 
6 or 24 hr with 0.5 µmol/L of Aβ1-42 oligomers (AβO) in the presence or in the absence of 
25 µmol/L ZVAD-fmk. A) Basal intracellular Ca2+ levels were measured using fluorescent 
Ca2+ indicator Indo-1/AM.  Primary cortical neurons were incubated with Indo-1/AM for 45 
min, followed by a 15 min post-loading period. Finally, Indo-1 fluorescence was recorded and 
the cytosolic Ca2+ concentration was calculated upon calibration with ionomycin and MnCl2. 
B) The number of apoptotic cells was quantified in untreated and treated cortical neurons by 
fluorescence microscopy using Hoechst 33342. The results were presented as the percentage 
of the total number of cells and represent the means ± SEM of at least three independent 
experiments performed in duplicate. **p<0.01 ***p<0.001, significantly different from 
control, in the absence of AβΟ treatment.   
 
ACCEPTED  MANUSCRIPT
AC
CE
PT
ED
 MA
NU
SC
RIP
T
Figure
Click here to download high resolution image
ACCEPTED  MANUSCRIPT
AC
CE
PT
ED
 MA
NU
SC
RIP
T
Figure
Click here to download high resolution image
ACCEPTED  MANUSCRIPT
AC
CE
PT
ED
 MA
NU
SC
RIP
T
Figure
Click here to download high resolution image
ACCEPTED  MANUSCRIPT
AC
CE
PT
ED
 MA
NU
SC
RIP
T
Figure
Click here to download high resolution image
ACCEPTED  MANUSCRIPT
AC
CE
PT
ED
 MA
NU
SC
RIP
T
Figure
Click here to download high resolution image
ACCEPTED  MANUSCRIPT
AC
CE
PT
ED
 MA
NU
SC
RIP
T
Figure
Click here to download high resolution image
ACCEPTED  MANUSCRIPT
AC
CE
PT
ED
 MA
NU
SC
RIP
T
Figure
Click here to download high resolution image
ACCEPTED  MANUSCRIPT
AC
CE
PT
ED
 MA
NU
SC
RIP
T
Figure
Click here to download high resolution image
ACCEPTED  MANUSCRIPT
AC
CE
PT
ED
 MA
NU
SC
RIP
T
Figure
Click here to download high resolution image
ACCEPTED  MANUSCRIPT
AC
CE
PT
ED
 MA
NU
SC
RIP
T
Figure
Click here to download high resolution image
ACCEPTED  MANUSCRIPT
AC
CE
PT
ED
 MA
NU
SC
RIP
T
Figure
Click here to download high resolution image
ACCEPTED  MANUSCRIPT
AC
CE
PT
ED
 MA
NU
SC
RIP
T
Figure
Click here to download high resolution image
ACCEPTED  MANUSCRIPT
AC
CE
PT
ED
 MA
NU
SC
RIP
T
Figure
Click here to download high resolution image
ACCEPTED  MANUSCRIPT
